Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

19 Feb 2019

Abstract excerpt

Abstract Peripheral T-cell lymphoma (PTCL) is a group of complex clinicopathological entities, often associated with an aggressive clinical course. Angioimmunoblastic T-cell lymphoma (AITL) and PTCL-not otherwise specified (PTCL-NOS) are the 2 most frequent categories, accounting for >50% of PTCLs. Gene expression profiling (GEP) defined molecular signatures for AITL and delineated biological and prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lymphoma Diagnosis and Treatment
Share to T-cell and Retrovirus Studies
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30782609
DOI: 10.1182/blood-2018-09-872549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaPMID 30782609Read ↗

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?Semantic proximity Read ↗

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profilingSemantic proximity Read ↗

Genetic Landscape and Classification of Peripheral T Cell Lymphomas.Semantic proximity Read ↗

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaSemantic proximity Read ↗

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomasSemantic proximity Read ↗

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)Semantic proximity Read ↗

The new biology of PTCL‐NOS and AITL: current status and future clinical impactSemantic proximity Read ↗

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesisSemantic proximity Read ↗

New insights in the pathogenesis of T-cell lymphomasSemantic proximity Read ↗

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers.Semantic proximity Read ↗

Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targetsSemantic proximity Read ↗

New insights into the biology of T-cell lymphomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.